Marchex (MCHX) Q3 2026 Earnings Call Transcript

Marchex (MCHX) reported Q3 2026 revenue of $16M, up from $15.2M in 2025, with net income of $1.3M, reversing a loss from the prior year. Adjusted EBITDA was $2.4M, with a margin of 15%. Guidance for Q4 revenue is $15M+, with adjusted EBITDA between $2.3M and $2.5M. The company aims for $100M+ annual revenue by 2027, driven by AI and automation initiatives.

Original reporting
Published Nov 11, 2026, 3:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 4:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Marchex (MCHX) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$MCHXNeutralMed
01

Why it matters

The earnings beat on profit but miss on revenue guidance may cause short‑term volatility; long‑term investors may focus on AI integration opportunities.

02

Market read

First disclosure of Q3 earnings and FY guidance for Marchex, a small‑cap tech stock, providing fresh data for traders.

03

What to watch

Potential upside from the automotive OEM partnership and incremental $1M+ customer pipeline.

Relevance 7/10Novelty 8/10Timing: today

Background

Marchex reported its Q3 2026 results, marking a return to GAAP profitability after the Archenia acquisition and outlined FY guidance.

Company-level read

Ticker impact

$MCHXNeutralHigh confidence
Context

Q3 2026 earnings release with GAAP net income, revenue growth and FY guidance disclosed for the first time.

Expected impact

potential downside pressure as Q4 revenue guidance is below prior expectations.

Evidence & confidence

Investors will weigh the positive GAAP profit against the weaker revenue outlook, likely prompting a modest sell-off.

Market effects

Highlights growing importance of AI‑driven conversational analytics in the enterprise software sector.

Limited to U.S. small‑cap tech space; no broader regional effect.

Low; the story is company‑specific.

Counterpoint

The revenue guidance dip may be temporary; AI‑voice agent pipeline could accelerate growth beyond guidance.

Key entities

  • Marchex, Inc.

    U.S. listed provider of conversational analytics and AI‑driven solutions.

  • Archenia

    AI‑voice agent firm acquired by Marchex in July 2026.

Related articles

$MCHXMed

What Marchex (MCHX) Said on Its Q3 Earnings Call

Marchex (MCHX) reported Q3 earnings, highlighting $400K annualized revenue from a new AI Voice Agent deployment and expecting $200K more in 2027. The company aims for $15M+ revenue and $2.3M-$2.5M adjusted EBITDA in Q4, with a long-term goal of $100M+ annual revenue. Marchex also appointed Travis Fairchild as president.

$MCHXMed

Marchex Returns to Revenue Growth and Profitability in Third Quarter 2026 Generates $1.3 Million in GAAP Net Income and $2.6 Million in Adjusted EBITDA (net…

MARCHEX INC (MCHX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Marchex Returns to Revenue Growth and Profitability in Third Quarter 2026 Generates $1.3 Million in GAAP Net Income and $2.6 Million in Adjusted EBITDA (net of reorganization costs) Highlights Early Commercial Momentum Following Archenia Acquisition; Appoints Travis

$MCHXMed

Marchex Announces Second Quarter 2026 Financial Results

MARCHEX INC (MCHX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Marchex Announces Second Quarter 2026 Financial Results Reports Improved Profitability and Early Momentum Following Archenia Acquisition SEATTLE, WA – August 12, 2026 – Marchex, Inc. (NASDAQ: MCHX), a vertically focused, AI-driven conversation analytics, customer acq